1. 2022
  2. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

    Hodiamont, C. J., van den Broek, A. K., de Vroom, S. L., Prins, J. M., Mathôt, R. A. A. & van Hest, R. M., Aug 2022, In: Clinical pharmacokinetics. 61, 8, p. 1075-1094 20 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. 2021
  4. Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients

    Hodiamont, C. J., Juffermans, N. P., Berends, S. E., van Vessem, D. J., Hakkens, N., Mathôt, R. A. A., de Jong, M. D. & van Hest, R. M., 1 Nov 2021, In: Journal of antimicrobial chemotherapy. 76, 11, p. 2941-2949 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients

    Haksteen, W. E., Hilderink, B. N., Dujardin, R. W. G., Jansen, R. R., Hodiamont, C. J., Tuinman, P. R., Smit, J. M., Müller, M. C. A. & Juffermans, N. P., 1 Oct 2021, In: Thrombosis research. 206, p. 128-130 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Population pharmacokinetics and probability of target attainment of different dosing regimens of ceftazidime in critically ill patients with a proven or suspected pseudomonas aeruginosa infection

    Buning, A. W., Hodiamont, C. J., Lechner, N. M., Schokkin, M., Elbers, P. W. G., Juffermans, N. P., Mathôt, R. A. A., de Jong, M. D. & van Hest, R. M., 1 Jun 2021, In: Antibiotics (Basel, Switzerland). 10, 6, 612.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2020
  8. Neonatal bacterial meningitis versus ventriculitis: a cohort-based overview of clinical characteristics, microbiology and imaging

    Peros, T., van Schuppen, J., Bohte, A., Hodiamont, C., Aronica, E. & de Haan, T., Dec 2020, In: European journal of pediatrics. 179, 12, p. 1969-1977 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Population Pharmacokinetics of Ganciclovir in Critically Ill Patients

    Krens, S. D., Hodiamont, C. J., Juffermans, N. P., Mathôt, R. A. A. & van Hest, R. M., 1 Apr 2020, In: Therapeutic drug monitoring. 42, 2, p. 295-301 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Microbiological profile of nosocomial infections following cardiac arrest: Insights from the targeted temperature management (TTM) trial

    Harmon, M. B. A., Hodiamont, C. J., Dankiewicz, J., Nielsen, N., Schultz, M. J., Horn, J., Friberg, H. & Juffermans, N. P., 1 Mar 2020, In: Resuscitation. 148, p. 227-233 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2019
  12. Evaluatie van een nieuwe Nederlandse vancomycine- doseerrichtlijn en populatiefarmacokinetiek van vancomycine bij preterme en a terme neonaten

    Koedood, L., de Haan, T. R., Hodiamont, C. J., van Haelst, I. M. M. & Mathot, R. A. A., 2019, In: Pharmaceutisch Weekblad. 154, 15, p. 19-23

    Research output: Contribution to journalArticleProfessional

  13. 2018
  14. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: A proof of principle study ISRCTN48328635 ISRCTN

    Singh, R., de Groot, P. F., Geerlings, S. E., Hodiamont, C. J., Belzer, C., Berge, I. J. M. T., de Vos, W. M., Bemelman, F. J. & Nieuwdorp, M., 2018, In: BMC research notes. 11, 1, 190.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 Next

ID: 60783